Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

ISR Immune System Regulation

Less than 1K followers
All
Webcasts
Press releases
3rd party
ShowingAll content types
Regulatory press release8/28/2023, 10:01 AM

ISR's, SARS-CoV-2 dry powder nasal - vaccine booster candidate, ISR52, demonstrates superior immune response, in mouse model challenge studies compared to subcutaneous injection of this vaccine.

ISR Immune System Regulation
Regulatory press release8/25/2023, 10:02 PM

ISR Immune System Regulation Holding AB (Publ.) styrelseledamot Anders Olsson Fogelberg lämnar sitt uppdrag av hälsoskäl.

ISR Immune System Regulation
Regulatory press release5/24/2023, 6:38 PM

Nasdaqs avnoteringsbeslut påverkar inte ingångna avtal rörande finansiering för ISR Holding AB (publ)

ISR Immune System Regulation

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/24/2023, 6:46 AM

Nasdaq Stockholms disciplinnämnd har beslutat att ISR Immune System Regulation Holding AB (publ):s aktier ska avnoteras från Nasdaq Frist North Growth Market

ISR Immune System Regulation
Regulatory press release5/22/2023, 7:01 AM

ISR: Information till aktieägare kring finansiering

ISR Immune System Regulation
Regulatory press release5/12/2023, 3:28 PM

ISR Immune System Regulation Holding AB (publ) flyttar årsstämman

ISR Immune System Regulation
Regulatory press release5/12/2023, 11:01 AM

ISR Immune System Regulation Holding AB (publ) kallar till extra bolagsstämma

ISR Immune System Regulation
Regulatory press release5/12/2023, 10:29 AM

ISR Immune System Regulation Holding AB (publ) kommer att kalla till en extra bolagsstämma för att besluta om val av ny valberedning

ISR Immune System Regulation
Regulatory press release4/7/2023, 8:21 AM

ISR Immune System Regulation Holding AB (publ) har informerats om att Nasdaq Stockholm AB beslutat att överlämna pågående utredningsärende till disciplinnämnden med yrkande om avnotering

ISR Immune System Regulation
Regulatory press release3/17/2023, 9:11 AM

ISR Immune System Regulation Holding AB (publ) har besvarat Nasdaqs anmärkningspåstående

ISR Immune System Regulation
Regulatory press release3/8/2023, 8:03 AM

ISR Immune System Regulation Holding AB (publ) har erhållit ett anmärkningspåstående från Nasdaq

ISR Immune System Regulation
ISR, Audiocast with teleconference, Q4'22
Webcast3/6/2023, 1:00 PM

ISR, Audiocast with teleconference, Q4'22

ISR Immune System Regulation
Regulatory press release3/2/2023, 6:59 PM

ISR inbjuder till Conference Call för marknadens intressenter Måndag den 6/3 kl 14.00-15.00

ISR Immune System Regulation
Regulatory press release2/28/2023, 5:20 PM

ISR Holding AB (publ) bokslutskommuniké för 2022

ISR Immune System Regulation
Regulatory press release2/28/2023, 4:44 PM

ISR Holding har beslutat om en riktad emission om 67 MSEK samt meddelar avsikt att besluta om en företrädesemission i närtid

ISR Immune System Regulation
Regulatory press release2/23/2023, 9:59 AM

ISR senarelägger bokslutskommunikén för 2022

ISR Immune System Regulation
Regulatory press release1/11/2023, 9:59 AM

Immunowise AB med ytterligare investerare och en aktieägarförening - säkerställer fortsatt drift av ISR tills dess att långsiktig finansieringslösning presenteras.

ISR Immune System Regulation
Regulatory press release12/9/2022, 10:46 AM

ISR's styrelseledamot Bengt Fellström lämnar ISR's styrelse

ISR Immune System Regulation
Regulatory press release12/8/2022, 4:01 PM

ISR's CSO Johan Sjödahl antar nyckelroll i ledningsgrupp i annat bolag

ISR Immune System Regulation
Regulatory press release12/7/2022, 3:45 PM

ISR kommenterar skuld och finansieringssituation samt framskjutet införande av kvartalsvis rapportering

ISR Immune System Regulation
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team